CTech's Tuesday Roundup of Israeli Tech News
Swedish Eltel beats homegrown defense contractors to Israeli military drone contract; Gett CEO confirms planned IPO in Financial Times interview
Swedish Eltel beats homegrown defense contractors to Israeli military drone contract. The drones will be used as observation drones in the military’s infantry units. Read more
Gett CEO confirms planned IPO in Financial Times interview. According to Gett CEO Dave Shahar Waiser the taxi-hailing company is considering listing on either the London Stock Exchange or in the Tel Aviv Stock Exchange by the end of the year. Read more
Dell backs cancer diagnosis startup Ibex. Ibex develops software that uses data from digitized glass slides and electronic medical records to identify cancerous cells in tissue biopsies. Read more
Migraine treatment startup Theranica raises $35 million. The company develops electrical nerve stimulation (ENS) technology for controlling migraines. Read more
Nvidia enters a collaboration with Israeli data startup Iguazio. Iguazio offers data management services and artificial intelligence tools designed to improve the performance, security, and scalability of machine learning applications. Read more
Israel Infrastructure Partners launches debut fund with a $350 million goal. The Tel Aviv-based firm focuses on the infrastructure sector, with the aim of facilitating foreign investments in Israel. Read more
Economist: Tel Aviv is the tenth most expensive city in the world. A survey released Monday, compared the prices of more than 160 products and services in cities around the world, found Paris, Singapore, and Hong Kong to be the most expensive. Read more
Arizona's Grayhawk Capital launches $75 million early growth fund. The firm announced Monday it is appointing a new venture partner to focus on investments in Israel. Read more
Twitter unveils special emoji for Israeli election. The emoji, which depicts the emblem of the State of Israel, shows a menorah surrounded by an olive branch on each side with a dark blue backdrop. Read more
Senior vice president David Lustig leaving Teva after 25 years. Lustig will be replaced by Miran Denac, currently senior vice president and cluster manager for central and Western Europe operations. Read more